XORTX Therapeutics Inc (TSE:XRTX) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
XORTX Therapeutics Inc. has appointed Dr. Michael Bumby as the new Chief Financial Officer, bringing his extensive experience in finance and leadership within the biotech and pharma industries. The appointment is expected to provide strategic financial guidance to the company as it advances its clinical development programs.
For further insights into TSE:XRTX stock, check out TipRanks’ Stock Analysis page.
